OBJECTIVES: Reinfection after treatment for Chlamydia trachomatis or Neisseria gonorrhoeae reduces the effect of control interventions. We explored the impact of delays in treatment of current partners on the expected probability of reinfection of index cases using a mathematical model. METHODS: We used previously reported parameter distributions to calculate the probability that index cases would be reinfected by their untreated partners. We then assumed different delays between index case and partner treatment to calculate the probabilities of reinfection. RESULTS: In the absence of partner treatment, the medians of the expected reinfection probabilities are 19.4% (IQR 9.2-31.6%) for C trachomatis and 12.5% (IQR 5.6-22.2%) for N gonorrhoeae. If all current partners receive treatment 3 days after the index case, the expected reinfection probabilities are 4.2% (IQR 2.1-6.9%) for C trachomatis and 5.5% (IQR 2.6-9.5%) for N gonorrhoeae. CONCLUSIONS: Quicker partner referral and treatment can substantially reduce reinfection rates for C trachomatis and N gonorrhoeae by untreated partners. The formula we used to calculate reinfection rates can be used to inform the design of randomised controlled trials of novel partner notification technologies like accelerated partner therapy.
OBJECTIVES: Reinfection after treatment for Chlamydia trachomatis or Neisseria gonorrhoeae reduces the effect of control interventions. We explored the impact of delays in treatment of current partners on the expected probability of reinfection of index cases using a mathematical model. METHODS: We used previously reported parameter distributions to calculate the probability that index cases would be reinfected by their untreated partners. We then assumed different delays between index case and partner treatment to calculate the probabilities of reinfection. RESULTS: In the absence of partner treatment, the medians of the expected reinfection probabilities are 19.4% (IQR 9.2-31.6%) for C trachomatis and 12.5% (IQR 5.6-22.2%) for N gonorrhoeae. If all current partners receive treatment 3 days after the index case, the expected reinfection probabilities are 4.2% (IQR 2.1-6.9%) for C trachomatis and 5.5% (IQR 2.6-9.5%) for N gonorrhoeae. CONCLUSIONS: Quicker partner referral and treatment can substantially reduce reinfection rates for C trachomatis and N gonorrhoeae by untreated partners. The formula we used to calculate reinfection rates can be used to inform the design of randomised controlled trials of novel partner notification technologies like accelerated partner therapy.
Authors: Samuel M Jenness; Kevin M Weiss; Steven M Goodreau; Thomas Gift; Harrell Chesson; Karen W Hoover; Dawn K Smith; Albert Y Liu; Patrick S Sullivan; Eli S Rosenberg Journal: Clin Infect Dis Date: 2017-09-01 Impact factor: 9.079
Authors: Claudia S Estcourt; Lorna J Sutcliffe; Andrew Copas; Catherine H Mercer; Tracy E Roberts; Louise J Jackson; Merle Symonds; Laura Tickle; Pamela Muniina; Greta Rait; Anne M Johnson; Kazeem Aderogba; Sarah Creighton; Jackie A Cassell Journal: Sex Transm Infect Date: 2015-05-27 Impact factor: 3.519
Authors: Maartje Visser; Fleur van Aar; Femke D H Koedijk; Carolina J G Kampman; Janneke C M Heijne Journal: BMC Infect Dis Date: 2017-12-20 Impact factor: 3.090
Authors: Minttu M Rönn; Ashleigh R Tuite; Nicolas A Menzies; Emory E Wolf; Thomas L Gift; Harrell W Chesson; Elizabeth Torrone; Andrés Berruti; Emanuele Mazzola; Kara Galer; Katherine Hsu; Joshua A Salomon Journal: Am J Epidemiol Date: 2019-03-01 Impact factor: 4.897